DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · IEX Real-Time Price · USD
0.840
+0.004 (0.48%)
At close: Jul 19, 2024, 4:00 PM
0.990
+0.150 (17.86%)
Pre-market: Jul 22, 2024, 7:35 AM EDT
DBV Technologies Market Cap
DBV Technologies has a market cap or net worth of $80.83 million as of July 22, 2024. Its market cap has decreased by -75.75% in one year.
Market Cap
80.83M
Enterprise Value
-22.05M
1-Year Change
-75.75%
Ranking
Category
Stock Price
$0.84
Market Cap Chart
Since October 22, 2014, DBV Technologies's market cap has decreased from $844.80M to $80.83M, a decrease of -90.43%. That is a compound annual growth rate of -21.40%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 81.00M | -55.86% |
| Dec 29, 2023 | 183.50M | -36.22% |
| Dec 30, 2022 | 287.70M | 63.47% |
| Dec 31, 2021 | 176.00M | -28.57% |
| Dec 31, 2020 | 246.40M | -68.16% |
| Dec 31, 2019 | 773.80M | 141.13% |
| Dec 31, 2018 | 320.90M | -73.54% |
| Dec 29, 2017 | 1.21B | -28.69% |
| Dec 30, 2016 | 1.70B | 22.23% |
| Dec 31, 2015 | 1.39B | 39.07% |
| Dec 31, 2014 | 1.00B | 18.43% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sangamo Therapeutics | 82.40M |
| Instil Bio | 82.27M |
| Genenta Science | 82.16M |
| BioAtla | 81.80M |
| Serina Therapeutics | 81.70M |
| Chimerix | 80.66M |
| Protalix BioTherapeutics | 80.65M |
| SCYNEXIS | 80.47M |